메뉴 건너뛰기




Volumn 16, Issue 1, 2017, Pages

Hypertriglyceridemia and atherosclerosis

Author keywords

Atherosclerosis; Atherosclerotic cardiovascular disease; Lipoprotein; Triglyceride

Indexed keywords

ATORVASTATIN; EZETIMIBE; FENOFIBRATE; FENOFIBRATE PLUS SIMVASTATIN; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAROPIPRANT PLUS NICOTINIC ACID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; NICOTINIC ACID PLUS SIMVASTATIN; OMEGA 3 FATTY ACID; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG;

EID: 85045196048     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/s12944-017-0625-0     Document Type: Review
Times cited : (185)

References (87)
  • 2
    • 84857637931 scopus 로고    scopus 로고
    • Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: The evidence, etiology, and therapeutic challenges
    • Sampson UK, Fazio S, Linton MF. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges. Curr Atheroscler Rep. 2012;14:1-10.
    • (2012) Curr Atheroscler Rep , vol.14 , pp. 1-10
    • Sampson, U.K.1    Fazio, S.2    Linton, M.F.3
  • 4
    • 84899549076 scopus 로고    scopus 로고
    • Low nonfasting triglycerides and reduced all-cause mortality: A mendelian randomization study
    • Thomsen M, Varbo A, Tybjaerg-Hansen A, Nordestgaard BG. Low nonfasting triglycerides and reduced all-cause mortality: a mendelian randomization study. Clin Chem. 2014;60:737-46.
    • (2014) Clin Chem , vol.60 , pp. 737-746
    • Thomsen, M.1    Varbo, A.2    Tybjaerg-Hansen, A.3    Nordestgaard, B.G.4
  • 6
    • 84871705238 scopus 로고    scopus 로고
    • Using Mendelian randomization to determine causative factors in cardiovascular disease
    • Johansen CT, Hegele RA. Using Mendelian randomization to determine causative factors in cardiovascular disease. J Intern Med. 2013;273:44-7.
    • (2013) J Intern Med , vol.273 , pp. 44-47
    • Johansen, C.T.1    Hegele, R.A.2
  • 7
    • 84876175810 scopus 로고    scopus 로고
    • Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
    • Jorgensen AB, Frikke-Schmidt R, West AS, Grande P, Nordestgaard BG, Tybjaerg-Hansen A. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J. 2013;34:1826-33.
    • (2013) Eur Heart J , vol.34 , pp. 1826-1833
    • Jorgensen, A.B.1    Frikke-Schmidt, R.2    West, A.S.3    Grande, P.4    Nordestgaard, B.G.5    Tybjaerg-Hansen, A.6
  • 8
  • 9
    • 84958279785 scopus 로고    scopus 로고
    • Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics
    • Julve J, Martin-Campos JM, Escola-Gil JC, Blanco-Vaca F. Chylomicrons: advances in biology, pathology, laboratory testing, and therapeutics. Clin Chim Acta. 2016;455:134-48.
    • (2016) Clin Chim Acta , vol.455 , pp. 134-148
    • Julve, J.1    Martin-Campos, J.M.2    Escola-Gil, J.C.3    Blanco-Vaca, F.4
  • 13
    • 74549148035 scopus 로고    scopus 로고
    • Cholesteryl ester transfer protein: At the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors
    • Chapman MJ, Le Goff W, Guerin M, Kontush A. Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors. Eur Heart J. 2010;31:149-64.
    • (2010) Eur Heart J , vol.31 , pp. 149-164
    • Chapman, M.J.1    Le Goff, W.2    Guerin, M.3    Kontush, A.4
  • 15
    • 85020180173 scopus 로고    scopus 로고
    • Triglyceride rich lipoprotein -LPL-VLDL receptor and Lp(a)-VLDL receptor pathways for macrophage foam cell formation
    • Takahashi S. Triglyceride rich lipoprotein -LPL-VLDL receptor and Lp(a)-VLDL receptor pathways for macrophage foam cell formation. J Atheroscler Thromb. 2017;24:552-9.
    • (2017) J Atheroscler Thromb , vol.24 , pp. 552-559
    • Takahashi, S.1
  • 16
    • 83755220620 scopus 로고    scopus 로고
    • Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis
    • Fogelstrand P, Boren J. Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr Metab Cardiovasc Dis. 2012;22:1-7.
    • (2012) Nutr Metab Cardiovasc Dis , vol.22 , pp. 1-7
    • Fogelstrand, P.1    Boren, J.2
  • 17
    • 84896740238 scopus 로고    scopus 로고
    • Postprandial hypertriglyceridemia as a coronary risk factor
    • Boren J, Matikainen N, Adiels M, Taskinen MR. Postprandial hypertriglyceridemia as a coronary risk factor. Clin Chim Acta. 2014;431:131-42.
    • (2014) Clin Chim Acta , vol.431 , pp. 131-142
    • Boren, J.1    Matikainen, N.2    Adiels, M.3    Taskinen, M.R.4
  • 18
    • 84925469494 scopus 로고    scopus 로고
    • Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
    • Rosenson RS, Davidson MH, Hirsh BJ, Kathiresan S, Gaudet D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64:2525-40.
    • (2014) J Am Coll Cardiol , vol.64 , pp. 2525-2540
    • Rosenson, R.S.1    Davidson, M.H.2    Hirsh, B.J.3    Kathiresan, S.4    Gaudet, D.5
  • 19
    • 84879094909 scopus 로고    scopus 로고
    • Ectopic lipid storage and insulin resistance: A harmful relationship
    • Boren J, Taskinen MR, Olofsson SO, Levin M. Ectopic lipid storage and insulin resistance: a harmful relationship. J Intern Med. 2013;274:25-40.
    • (2013) J Intern Med , vol.274 , pp. 25-40
    • Boren, J.1    Taskinen, M.R.2    Olofsson, S.O.3    Levin, M.4
  • 20
    • 84906259943 scopus 로고    scopus 로고
    • Triglycerides and cardiovascular disease
    • Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384:626-35.
    • (2014) Lancet , vol.384 , pp. 626-635
    • Nordestgaard, B.G.1    Varbo, A.2
  • 21
    • 0042691798 scopus 로고    scopus 로고
    • Intimal retention of cholesterol derived from apolipoprotein B100- And apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits
    • Proctor SD, Mamo JC. Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2003;23:1595-600.
    • (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1595-1600
    • Proctor, S.D.1    Mamo, J.C.2
  • 22
    • 39649120533 scopus 로고    scopus 로고
    • Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases
    • Nakano T, Nakajima K, Niimi M, Fujita MQ, Nakajima Y, Takeichi S, Kinoshita M, Matsushima T, Teramoto T, Tanaka A. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clin Chim Acta. 2008;390:38-43.
    • (2008) Clin Chim Acta , vol.390 , pp. 38-43
    • Nakano, T.1    Nakajima, K.2    Niimi, M.3    Fujita, M.Q.4    Nakajima, Y.5    Takeichi, S.6    Kinoshita, M.7    Matsushima, T.8    Teramoto, T.9    Tanaka, A.10
  • 23
    • 0038573898 scopus 로고    scopus 로고
    • Identification of lipoproteins of intestinal origin in human atherosclerotic plaque
    • Pal S, Semorine K, Watts GF, Mamo J. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med. 2003; 41:792-5.
    • (2003) Clin Chem Lab Med , vol.41 , pp. 792-795
    • Pal, S.1    Semorine, K.2    Watts, G.F.3    Mamo, J.4
  • 25
    • 68049114763 scopus 로고    scopus 로고
    • Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease
    • Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, et al. Plasma triglycerides and cardiovascular events in the treating to new targets and incremental decrease in end-points through aggressive lipid lowering trials of statins in patients with coronary artery disease. Am J Cardiol. 2009;104:459-63.
    • (2009) Am J Cardiol , vol.104 , pp. 459-463
    • Faergeman, O.1    Holme, I.2    Fayyad, R.3    Bhatia, S.4    Grundy, S.M.5    Kastelein, J.J.6    LaRosa, J.C.7    Larsen, M.L.8    Lindahl, C.9    Olsson, A.G.10
  • 26
    • 85056556748 scopus 로고    scopus 로고
    • Postprandial dyslipidemia: Pathophysiology and cardiovascular disease risk assessment
    • Higgins V, Adeli K. Postprandial Dyslipidemia: Pathophysiology and cardiovascular disease risk assessment. Ejifcc. 2017;28:168-84.
    • (2017) Ejifcc , vol.28 , pp. 168-184
    • Higgins, V.1    Adeli, K.2
  • 27
    • 57149133676 scopus 로고    scopus 로고
    • Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction
    • Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118: 2047-56.
    • (2008) Circulation , vol.118 , pp. 2047-2056
    • Langsted, A.1    Freiberg, J.J.2    Nordestgaard, B.G.3
  • 28
    • 34447511196 scopus 로고    scopus 로고
    • Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
    • Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299-308.
    • (2007) JAMA , vol.298 , pp. 299-308
    • Nordestgaard, B.G.1    Benn, M.2    Schnohr, P.3    Tybjaerg-Hansen, A.4
  • 29
    • 63449095758 scopus 로고    scopus 로고
    • Plasma lipids in non-fasting patients and signal values of laboratory results
    • Nordestgaard BG, Hilsted L, Stender S. Plasma lipids in non-fasting patients and signal values of laboratory results. Ugeskr Laeger. 2009;171:1093.
    • (2009) Ugeskr Laeger , vol.171 , pp. 1093
    • Nordestgaard, B.G.1    Hilsted, L.2    Stender, S.3
  • 30
    • 84973465396 scopus 로고    scopus 로고
    • Fasting is not routinely required for determination of a lipid profile: Clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European atherosclerosis society and European Federation of Clinical Chemistry and Laboratory Medicine
    • Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, Watts GF, Sypniewska G, Wiklund O, Boren J, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European atherosclerosis society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016; 37:1944-58.
    • (2016) Eur Heart J , vol.37 , pp. 1944-1958
    • Nordestgaard, B.G.1    Langsted, A.2    Mora, S.3    Kolovou, G.4    Baum, H.5    Bruckert, E.6    Watts, G.F.7    Sypniewska, G.8    Wiklund, O.9    Boren, J.10
  • 31
    • 34948857431 scopus 로고    scopus 로고
    • Methodology for studying postprandial lipid metabolism
    • Lairon D, Lopez-Miranda J, Williams C. Methodology for studying postprandial lipid metabolism. Eur J Clin Nutr. 2007;61:1145-61.
    • (2007) Eur J Clin Nutr , vol.61 , pp. 1145-1161
    • Lairon, D.1    Lopez-Miranda, J.2    Williams, C.3
  • 33
    • 0035941990 scopus 로고    scopus 로고
    • Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The diabetes atherosclerosis intervention study, a randomised study
    • Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the diabetes atherosclerosis intervention study, a randomised study. Lancet. 2001;357:905-10.
    • (2001) Lancet , vol.357 , pp. 905-910
  • 34
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
    • Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366:1849-61.
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3    Best, J.4    Scott, R.5    Taskinen, M.R.6    Forder, P.7    Pillai, A.8    Davis, T.9    Glasziou, P.10
  • 35
    • 0037840242 scopus 로고    scopus 로고
    • MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
    • Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-16.
    • (2003) Lancet , vol.361 , pp. 2005-2016
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleigh, P.4    Peto, R.5
  • 36
    • 34447328718 scopus 로고    scopus 로고
    • Niacin plus Simvastatin reduces coronary Stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: A subgroup analysis of the HDL-atherosclerosis treatment study (HATS)
    • Vittone F, Chait A, Morse JS, Fish B, Brown BG, Zhao XQ. Niacin plus Simvastatin reduces coronary Stenosis progression among patients with metabolic syndrome despite a modest increase in insulin resistance: a subgroup analysis of the HDL-atherosclerosis treatment study (HATS). J Clin Lipidol. 2007;1:203-10.
    • (2007) J Clin Lipidol , vol.1 , pp. 203-210
    • Vittone, F.1    Chait, A.2    Morse, J.S.3    Fish, B.4    Brown, B.G.5    Zhao, X.Q.6
  • 38
    • 84877299845 scopus 로고    scopus 로고
    • HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: Trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
    • HPS2-THRIVE Collaborative Group. HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J. 2013;34:1279-91.
    • (2013) Eur Heart J , vol.34 , pp. 1279-1291
  • 40
    • 84928887902 scopus 로고    scopus 로고
    • Increasing HDL-cholesterol and prevention of atherosclerosis: A critical perspective
    • Parhofer KG. Increasing HDL-cholesterol and prevention of atherosclerosis: a critical perspective. Atheroscler Suppl. 2015;18:109-11.
    • (2015) Atheroscler Suppl , vol.18 , pp. 109-111
    • Parhofer, K.G.1
  • 42
    • 84983120376 scopus 로고    scopus 로고
    • Fasting and nonfasting triglycerides in cardiovascular and other diseases
    • Pitha J, Kovar J, Blahova T. Fasting and nonfasting triglycerides in cardiovascular and other diseases. Physiol Res. 2015;64(Suppl 3):S323-30.
    • (2015) Physiol Res , vol.64 , pp. S323-S330
    • Pitha, J.1    Kovar, J.2    Blahova, T.3
  • 43
    • 84866741048 scopus 로고    scopus 로고
    • The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis
    • Brunzell JD, Schrott HG. The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis. J Clin Lipidol. 2012;6:409-12.
    • (2012) J Clin Lipidol , vol.6 , pp. 409-412
    • Brunzell, J.D.1    Schrott, H.G.2
  • 44
    • 84966280638 scopus 로고    scopus 로고
    • Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease
    • Toth PP. Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease. Vasc Health Risk Manag. 2016;12:171-83.
    • (2016) Vasc Health Risk Manag , vol.12 , pp. 171-183
    • Toth, P.P.1
  • 45
    • 85021711514 scopus 로고    scopus 로고
    • Food and plant bioactives for reducing cardiometabolic disease risk: An evidence based approach
    • Cicero AFG, Fogacci F, Colletti A. Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach. Food Funct. 2017;8:2076-88.
    • (2017) Food Funct , vol.8 , pp. 2076-2088
    • Cicero, A.F.G.1    Fogacci, F.2    Colletti, A.3
  • 47
    • 84992092089 scopus 로고    scopus 로고
    • ESC/EAS guidelines for the Management of Dyslipidaemias: The task force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
    • Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, et al. ESC/EAS guidelines for the Management of Dyslipidaemias: the task force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European atherosclerosis society (EAS) developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016;2016(253):281-344.
    • (2016) Atherosclerosis , vol.2016 , Issue.253 , pp. 281-344
    • Catapano, A.L.1    Graham, I.2    De Backer, G.3    Wiklund, O.4    Chapman, M.J.5    Drexel, H.6    Hoes, A.W.7    Jennings, C.S.8    Landmesser, U.9    Pedersen, T.R.10
  • 50
    • 85020011219 scopus 로고    scopus 로고
    • Genetics of triglycerides and the risk of atherosclerosis
    • Dron JS, Hegele RA. Genetics of triglycerides and the risk of atherosclerosis. Curr Atheroscler Rep. 2017;19:31.
    • (2017) Curr Atheroscler Rep , vol.19 , pp. 31
    • Dron, J.S.1    Hegele, R.A.2
  • 51
    • 84875444149 scopus 로고    scopus 로고
    • Hypertriglyceridemia
    • Brahm A, Hegele RA. Hypertriglyceridemia. Nutrients. 2013;5:981-1001.
    • (2013) Nutrients , vol.5 , pp. 981-1001
    • Brahm, A.1    Hegele, R.A.2
  • 52
    • 84960511059 scopus 로고    scopus 로고
    • Therapeutic targets of triglyceride metabolism as informed by human genetics
    • Bauer RC, Khetarpal SA, Hand NJ, Rader DJ. Therapeutic targets of triglyceride metabolism as informed by human genetics. Trends Mol Med. 2016;22:328-40.
    • (2016) Trends Mol Med , vol.22 , pp. 328-340
    • Bauer, R.C.1    Khetarpal, S.A.2    Hand, N.J.3    Rader, D.J.4
  • 54
    • 84883304683 scopus 로고    scopus 로고
    • Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation
    • Aung HH, Lame MW, Gohil K, An CI, Wilson DW, Rutledge JC. Induction of ATF3 gene network by triglyceride-rich lipoprotein lipolysis products increases vascular apoptosis and inflammation. Arterioscler Thromb Vasc Biol. 2013;33:2088-96.
    • (2013) Arterioscler Thromb Vasc Biol , vol.33 , pp. 2088-2096
    • Aung, H.H.1    Lame, M.W.2    Gohil, K.3    An, C.I.4    Wilson, D.W.5    Rutledge, J.C.6
  • 55
    • 84990841025 scopus 로고    scopus 로고
    • Eating and arterial endothelial function: A meta-analysis of the acute effects of meal consumption on flow-mediated dilation
    • Thom NJ, Early AR, Hunt BE, Harris RA, Herring MP. Eating and arterial endothelial function: a meta-analysis of the acute effects of meal consumption on flow-mediated dilation. Obes Rev. 2016;17:1080-90.
    • (2016) Obes Rev , vol.17 , pp. 1080-1090
    • Thom, N.J.1    Early, A.R.2    Hunt, B.E.3    Harris, R.A.4    Herring, M.P.5
  • 59
    • 84897081454 scopus 로고    scopus 로고
    • The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction
    • Matsumoto S, Gotoh N, Hishinuma S, Abe Y, Shimizu Y, Katano Y, Ishihata A. The role of hypertriglyceridemia in the development of atherosclerosis and endothelial dysfunction. Nutrients. 2014;6:1236-50.
    • (2014) Nutrients , vol.6 , pp. 1236-1250
    • Matsumoto, S.1    Gotoh, N.2    Hishinuma, S.3    Abe, Y.4    Shimizu, Y.5    Katano, Y.6    Ishihata, A.7
  • 60
    • 64749100482 scopus 로고    scopus 로고
    • Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation
    • Wang L, Gill R, Pedersen TL, Higgins LJ, Newman JW, Rutledge JC. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J Lipid Res. 2009;50:204-13.
    • (2009) J Lipid Res , vol.50 , pp. 204-213
    • Wang, L.1    Gill, R.2    Pedersen, T.L.3    Higgins, L.J.4    Newman, J.W.5    Rutledge, J.C.6
  • 61
    • 34548166870 scopus 로고    scopus 로고
    • Remnant-like lipoprotein particles impair endothelial function: Direct and indirect effects on nitric oxide synthase
    • Zheng XY, Liu L. Remnant-like lipoprotein particles impair endothelial function: direct and indirect effects on nitric oxide synthase. J Lipid Res. 2007;48:1673-80.
    • (2007) J Lipid Res , vol.48 , pp. 1673-1680
    • Zheng, X.Y.1    Liu, L.2
  • 62
    • 84899489650 scopus 로고    scopus 로고
    • Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications
    • Higashi Y, Maruhashi T, Noma K, Kihara Y. Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications. Trends Cardiovasc Med. 2014;24:165-9.
    • (2014) Trends Cardiovasc Med , vol.24 , pp. 165-169
    • Higashi, Y.1    Maruhashi, T.2    Noma, K.3    Kihara, Y.4
  • 63
    • 84933055337 scopus 로고    scopus 로고
    • Association between hypertriglyceridemia and protein oxidation and proinflammatory markers in normocholesterolemic and hypercholesterolemic individuals
    • Klafke JZ, Porto FG, Batista R, Bochi GV, Moresco RN, da Luz PL, Viecili PR. Association between hypertriglyceridemia and protein oxidation and proinflammatory markers in normocholesterolemic and hypercholesterolemic individuals. Clin Chim Acta. 2015;448:50-7.
    • (2015) Clin Chim Acta , vol.448 , pp. 50-57
    • Klafke, J.Z.1    Porto, F.G.2    Batista, R.3    Bochi, G.V.4    Moresco, R.N.5    Da Luz, P.L.6    Viecili, P.R.7
  • 65
    • 52449110622 scopus 로고    scopus 로고
    • Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: The good, the bad, and the ugly
    • Dickhout JG, Basseri S, Austin RC. Macrophage function and its impact on atherosclerotic lesion composition, progression, and stability: the good, the bad, and the ugly. Arterioscler Thromb Vasc Biol. 2008;28:1413-5.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , pp. 1413-1415
    • Dickhout, J.G.1    Basseri, S.2    Austin, R.C.3
  • 66
    • 84871186216 scopus 로고    scopus 로고
    • Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation
    • Rosenblat M, Volkova N, Paland N, Aviram M. Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation. Biofactors. 2012;38:458-69.
    • (2012) Biofactors , vol.38 , pp. 458-469
    • Rosenblat, M.1    Volkova, N.2    Paland, N.3    Aviram, M.4
  • 67
    • 34250850851 scopus 로고    scopus 로고
    • The induction of macrophage foam cell formation by chylomicron remnants
    • Botham KM, Moore EH, De Pascale C, Bejta F. The induction of macrophage foam cell formation by chylomicron remnants. Biochem Soc Trans. 2007;35:454-8.
    • (2007) Biochem Soc Trans , vol.35 , pp. 454-458
    • Botham, K.M.1    Moore, E.H.2    De Pascale, C.3    Bejta, F.4
  • 68
    • 34347233104 scopus 로고    scopus 로고
    • Which is the best anthropometric technique to identify obesity: Body mass index, waist circumference or waist-hip ratio?
    • Akpinar E, Bashan I, Bozdemir N, Saatci E. Which is the best anthropometric technique to identify obesity: body mass index, waist circumference or waist-hip ratio? Coll Antropol. 2007;31:387-93.
    • (2007) Coll Antropol , vol.31 , pp. 387-393
    • Akpinar, E.1    Bashan, I.2    Bozdemir, N.3    Saatci, E.4
  • 71
    • 84886916904 scopus 로고    scopus 로고
    • Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress
    • Wang YI, Bettaieb A, Sun C, DeVerse JS, Radecke CE, Mathew S, Edwards CM, Haj FG, Passerini AG, Simon SI. Triglyceride-rich lipoprotein modulates endothelial vascular cell adhesion molecule (VCAM)-1 expression via differential regulation of endoplasmic reticulum stress. PLoS One. 2013;8:e78322.
    • (2013) PLoS One , vol.8
    • Wang, Y.I.1    Bettaieb, A.2    Sun, C.3    DeVerse, J.S.4    Radecke, C.E.5    Mathew, S.6    Edwards, C.M.7    Haj, F.G.8    Passerini, A.G.9    Simon, S.I.10
  • 72
    • 84976467920 scopus 로고    scopus 로고
    • Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cells
    • Bleda S, de Haro J, Varela C, Ferruelo A, Acin F. Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cells. Int J Cardiol. 2016;220:52-5.
    • (2016) Int J Cardiol , vol.220 , pp. 52-55
    • Bleda, S.1    De Haro, J.2    Varela, C.3    Ferruelo, A.4    Acin, F.5
  • 74
    • 84959535692 scopus 로고    scopus 로고
    • Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anti-coagulant, protein S
    • Moren X, Lhomme M, Bulla A, Sanchez JC, Kontush A, James RW. Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: association of paraoxonase with the anti-coagulant, protein S. Proteomics Clin Appl. 2016;10:230-8.
    • (2016) Proteomics Clin Appl , vol.10 , pp. 230-238
    • Moren, X.1    Lhomme, M.2    Bulla, A.3    Sanchez, J.C.4    Kontush, A.5    James, R.W.6
  • 75
    • 84908013293 scopus 로고    scopus 로고
    • Paraoxonase 1 and HDL maturation
    • Gugliucci A, Menini T. Paraoxonase 1 and HDL maturation. Clin Chim Acta. 2015;439:5-13.
    • (2015) Clin Chim Acta , vol.439 , pp. 5-13
    • Gugliucci, A.1    Menini, T.2
  • 76
    • 84871865547 scopus 로고    scopus 로고
    • High density lipoprotein biogenesis, cholesterol efflux, and immune cell function
    • Sorci-Thomas MG, Thomas MJ. High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. Arterioscler Thromb Vasc Biol. 2012;32:2561-5.
    • (2012) Arterioscler Thromb Vasc Biol , vol.32 , pp. 2561-2565
    • Sorci-Thomas, M.G.1    Thomas, M.J.2
  • 78
    • 84967048401 scopus 로고    scopus 로고
    • Diabetic dyslipidaemia and the atherosclerosis
    • Mark L, Dani G. Diabetic dyslipidaemia and the atherosclerosis. Orv Hetil. 2016;157:746-52.
    • (2016) Orv Hetil , vol.157 , pp. 746-752
    • Mark, L.1    Dani, G.2
  • 79
    • 85012869480 scopus 로고    scopus 로고
    • Possibility of new circulating atherosclerosis-related lipid markers measurement in medical and complete medical checkups: Small dense low-density lipoprotein cholesterol and lipoprotein lipase
    • Sumino H, Nakajima K, Murakami M. Possibility of new circulating atherosclerosis-related lipid markers measurement in medical and complete medical checkups: small dense low-density lipoprotein cholesterol and lipoprotein lipase. Rinsho Byori. 2016;64:298-307.
    • (2016) Rinsho Byori , vol.64 , pp. 298-307
    • Sumino, H.1    Nakajima, K.2    Murakami, M.3
  • 83
    • 1442335807 scopus 로고    scopus 로고
    • Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: Prevention by cilostazol
    • Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation. 2004; 109:1022-8.
    • (2004) Circulation , vol.109 , pp. 1022-1028
    • Shin, H.K.1    Kim, Y.K.2    Kim, K.Y.3    Lee, J.H.4    Hong, K.W.5
  • 86
    • 33947627537 scopus 로고    scopus 로고
    • Adiponectin as an anti-inflammatory factor
    • Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta. 2007;380:24-30.
    • (2007) Clin Chim Acta , vol.380 , pp. 24-30
    • Ouchi, N.1    Walsh, K.2
  • 87
    • 33746633023 scopus 로고    scopus 로고
    • Effects of VLDL and remnant particles on platelets
    • Olufadi R, Byrne CD. Effects of VLDL and remnant particles on platelets. Pathophysiol Haemost Thromb. 2006;35:281-91.
    • (2006) Pathophysiol Haemost Thromb , vol.35 , pp. 281-291
    • Olufadi, R.1    Byrne, C.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.